Suchergebnisse - "Brunetti, Oronzo"

PubPharm (175)

51

A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors : Toward Personalized Immuno-Oncology

enthalten in: Frontiers in immunology | 2021

von Shadbad, M. | Asadzadeh, Z. | Hosseinkhani, N. | +5

52

Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients

enthalten in: Oncology | 2021

von Casadei-Gardini, A. | Filippi, R. | Rimini, M. | +23

53

COVID Vaccination in Cancer Patients : What Vaccination Priority Strategies Should There Be?

enthalten in: Frontiers in oncology | 2021

von Silvestris, N. | Brunetti, O. | Bernardini, R. | +1

54

The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy : Lessons Learned and the Road Ahead

enthalten in: Frontiers in immunology | 2021

von Hosseinkhani, N. | Derakhshani, A. | Shadbad, M. | +7

55

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients : Lessons Learned and The Road Ahead

enthalten in: Frontiers in oncology | 2021

von Abdoli Shadbad, M. | Hosseinkhani, N. | Asadzadeh, Z. | +7

56

A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy : From Deciphering to Personalized Medicine

enthalten in: Frontiers in immunology | 2021

von Abdoli Shadbad, M. | Hemmat, N. | Khaze Shahgoli, V. | +7

57

The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI : A Meta-Analysis

enthalten in: Frontiers in oncology | 2021

von Abdoli Shadbad, M. | Hosseinkhani, N. | Asadzadeh, Z. | +3

58

Correction to : Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

enthalten in: Targeted oncology | 2020

von Orsi, G. | Tovoli, F. | Dadduzio, V. | +23

ErratumFor: Target Oncol. 2020 Dec;15(6):773-785. - PMID 33044683

59

Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

enthalten in: Targeted oncology | 2020

von Orsi, G. | Tovoli, F. | Dadduzio, V. | +23

ErratumIn: Target Oncol. 2020 Oct 28;:. - PMID 33113041

60

Targeting TGF-β-Mediated SMAD Signaling Pathway via Novel Recombinant Cytotoxin II : A Potent Protein from Naja naja oxiana Venom in Melanoma

enthalten in: Molecules (Basel, Switzerland) | 2020

von Derakhshani, A. | Silvestris, N. | Hemmat, N. | +9